Goldman Sachs increased its holdings in Zhongji Innolight (03308) by 3.2451 million shares, with each share priced at approximately HKD 946.49.
On July 30, Goldman Sachs increased its holdings in Zhongji Xuchuang (03308) by 3.2451 million shares, at a price of HKD 946.4902 per share, totaling approximately HKD 3.071 billion.
According to the latest data from the Hong Kong Stock Exchange, on July 30, Goldman Sachs Group increased its holdings in Zhongji Innolight (03308) by 3.2451 million shares, at a price of HKD 946.4902 per share, for a total amount of approximately HKD 3.071 billion. After the increase, the latest number of shares held is approximately 6.4878 million, and the latest holding percentage is 11.90%.
Related Articles
TONGSHIFU (00664) issued a profit warning, expecting a mid-term net profit of 1 million to 1.5 million yuan, a year-on-year decrease.
CHICMAX (02145) expects to achieve a mid-term revenue of approximately 3.718 billion to 3.759 billion yuan.
SINOPHARM (01099): China National Accord Medicines Corporation's net profit attributable to shareholders in the first half of the year was 606 million yuan, a year-on-year decrease of 8.97%.
TONGSHIFU (00664) issued a profit warning, expecting a mid-term net profit of 1 million to 1.5 million yuan, a year-on-year decrease.
CHICMAX (02145) expects to achieve a mid-term revenue of approximately 3.718 billion to 3.759 billion yuan.
SINOPHARM (01099): China National Accord Medicines Corporation's net profit attributable to shareholders in the first half of the year was 606 million yuan, a year-on-year decrease of 8.97%.
RECOMMEND
